IGF-BP5 Antibody

ProSci
Product Code: PSI-38-154
Product Group: Primary Antibodies
Supplier: ProSci
CodeSizePrice
PSI-38-154-0.05mg0.05mg£524.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Rabbit
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species: Human
Applications:
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Western Blot (WB)
Storage:
IGF-BP5 antibody is stable for at least 2 years from date of receipt at -20˚C. The reconstituted antibody is stable for at least two weeks at 2-8˚C. Frozen aliquots are stable for at least 6 months when stored at -20˚C. Avoid repeated freez

Images

1 / 3
To detect hIGF-BP5 by sandwich ELISA (using 100 ul/well antibody solution) a concentration of 0.25 ? 1.0 ug/ml of this antibody is required. This biotinylated polyclonal antibody, in conjunction with ProSci?s Polyclonal Anti-Human IGF-BP5 (38-289) as a capture antibody, allows the detection of at least 0.2 ? 0.4 ng/well of recombinant hIGF-BP5.
2 / 3
3 / 3

To detect hIGF-BP5 by sandwich ELISA (using 100 ul/well antibody solution) a concentration of 0.25 ? 1.0 ug/ml of this antibody is required. This biotinylated polyclonal antibody, in conjunction with ProSci?s Polyclonal Anti-Human IGF-BP5 (38-289) as a capture antibody, allows the detection of at least 0.2 ? 0.4 ng/well of recombinant hIGF-BP5.

Further Information

Additional Names:
IBP5, IBP5, Insulin-like growth factor-binding protein 5IBP-5
Application Note:
ELISA:

Sandwich:
To detect hIGF-BP5 by sandwich ELISA (using 100 μL/well antibody solution) a concentration of 0.25 - 1.0 μg/mL of this antibody is required. This biotinylated polyclonal antibody, in conjunction with our polyclonal Anti-Human IGF-BP5 as a capture antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant hIGF-BP5.

Western Blot:
To detect hIGF-BP5 by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 μg/mL. Used in conjunction with compatible secondary reagents the detection limit for recombinant hIGF-BP5 is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions.
Background:
IGF-BP5 is one of a family of proteins that bind to insulin-like growth factors (IGFs). IGFB-P5 is a multifunctional protein which acts not only as a traditional binding protein but also functions as a growth factor independent of IGFs to stimulate bone formation. Currently there are seven named IGF-BPs that form high affinity complexes with both IGFI and IGFII. IGF-BP5 is the major IGF-binding protein present in bone tissue and helps potentiate the action of IGFI on smooth muscle cells, fibroblasts or osteoblasts. Data shows that IGF-BP5 acts as a growth inhibitor and pro-apoptotic agent in breast cancer cells. IGF-BP5 overexpressing mice show an increase in neonatal mortality, reduced female fertility, whole-body growth inhibition and retarded muscle development.
Concentration:
batch dependent
Conjugate:
Biotin
Immunogen:
Produced from sera of rabbits pre-immunized with highly pure (>98%) recombinant hIGF-BP5. Human IGF-BP5 specific antibody was purified by affinity chromatography and then biotinylated.
NCBI Gene ID #:
3488
NCBI Official Name:
insulin-like growth factor binding protein 5
NCBI Official Symbol:
IGFBP5
NCBI Organism:
Homo sapiens
Physical State:
Lyophilized
Protein Accession #:
P24593
Protein GI Number:
124069
Research Area:
Antibody Pairs
Swissprot #:
P24593
User NOte:
Centrifuge vial prior to opening.